Tirzepetide is predominantly an agonist for the GIP receptor, and that pathway induces less nausea, Dr
Longer and more intense workouts may cause increased gastrointestinal issues, like nausea and stomach discomfort, so trainers focus on consistent, moderately intense workouts
A., Kolts, R
In conclusion, both Wegovy and Mounjaro offer promising options for individuals struggling with obesity or overweight conditions
The information below is based on findings from studies comparing the tirzepatide group to the semaglutide group, focusing on weight reduction, blood sugar control, and effects on major adverse cardiovascular events
Tirzepatide, a novel dual glucose-dependent insulinotropic polypeptide and GLP-1 receptor agonist, is currently being developed for the treatment of type 2 diabetes